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SObjective: This study assessed the sensitivity of helical computed tomography in the detection of pulmonary
metastases in patients with colorectal cancer and the role of video-assisted thoracoscopic surgery in patients
with pulmonary metastases.
Methods: A total of 120 operations for pulmonary metastases were performed in 91 patients with colorectal cancer.
All patients received an open thoracotomy that allowed full operative inspection and palpation. Clinical data, includ-
ing the size and number of pulmonarymetastasis, were retrospectively collected. The difference in the number of pul-
monarymetastases as determined by computed tomography scan and surgical findingswas determined and analyzed.
Results: Operative findings were consistent with the preoperative computed tomography scan reports in 64 of
the 120 operations (53.3%). In 32 operations (26.7%), additional metastatic tumors were identified at open
thoracotomy. The sensitivity of helical computed tomography in the detection of colorectal cancer metastatic
lesions ranged from 35.5% to 95.5%. Unilateral solitary lesion demonstrated on computed tomography scan
was an independent factor for the prediction of additional metastatic lesions (P ¼ .023).
Conclusions: The sensitivity of helical computed tomography scan in the detection of pulmonary metastases
can reach 95.5% in patients with colorectal cancer with a solitary metastatic lesion. A unilateral solitary lesion
demonstrated on preoperative computed tomography scan is an independent factor for prediction of additional
metastatic lesions. If feasible, video-assisted thoracoscopic surgery may be justified in patients with colorectal
cancer with solitary pulmonary metastases. (J Thorac Cardiovasc Surg 2011;141:1207-12)Colorectal cancer (CRC) is a leading cause of cancer-
related mortality worldwide. After curative resection for
CRC, distant metastases to the liver or lungs inevitably
will develop in more than 10% of patients.1 An aggressive,
multidisciplinary approach including surgical resection is
recommended for recurrent CRC.2,3 Numerous studies
have emphasized the role of surgical resection for
pulmonary metastases from CRC and concluded that
certain factors, including lymph node metastases, serum
carcinoembryonic antigen (CEA) level, number and size
of pulmonary metastases, disease-free interval, and resect-
ability, are related to surgical outcome.4-9 Although the
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The Journal of Thoracic and Carpulmonary metastases from CRC can improve long-term
survival and obtain better local control, some authors9,10
have argued that the retrospective nature of these studies
does not allow definitive conclusions. Instead, they
suggested a prospective trial should be undertaken
whenever feasible.9,10
The number of metastases demonstrated by chest com-
puted tomography (CT) is frequently used as a prognostic
factor, because CT findings are important in deciding
whether complete resection of pulmonary metastases can
be carried out. Some authors suggest the sensitivity of a CT
scan to be insufficient, and that complete manual exploration
during thoracotomy should be considered for patients under-
going pulmonary metastasectomy.11,12 A 2004 study
reported that the sensitivity of helical CT in the detection
of pulmonary metastases was only 78%, and concluded
that despite the use of helical CT, palpation of the lung is
still necessary.12 In contrast, another recent study suggested
that palpation is not mandatory, and the application of multi-
detector CT in conjunction with video-assisted thoraco-
scopic surgery (VATS) is appropriate for metastasectomy.13
The use of VATS in the resection of pulmonary metasta-
ses is debatable. Potential advantages of the minimally
invasive approach include smaller incisions, less postoper-
ative pain, and shorter hospitalization. However, some
disadvantages include difficulty localizing central tumors
and the possible exclusion of small lesions undetected by
CT scan, which could influence patient outcome.14 Thisdiovascular Surgery c Volume 141, Number 5 1207
Abbreviations and Acronyms
CEA ¼ carcinoembryonic antigen
CRC ¼ colorectal cancer
CT ¼ computed tomography
VATS ¼ video-assisted thoracoscopic surgery
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Sstudy assessed the accuracy of preoperative helical CT
scanning in patients with CRC with pulmonary metastases
and the role of VATS in these patients.
PATIENTS AND METHODS
Patients
From January 2000 to December 2009, 153 pulmonary metastasecto-
mies were performed in 120 patients with CRC at Taipei Veterans General
Hospital. The institutional review board of Taipei Veterans General Hospi-
tal approved this study and granted an exemption from informed consent on
August 26, 2010 (20100823IC). All patients received a current-generation
scanner, a 64-detector row CT scanner (Toshiba Aquilion 64 CT Scanner;
Toshiba Medical Systems Corp, Tochigi, Japan). The images were recon-
structed at intervals of 5 mm. Of these 120 patients, 91 who received an
open thoracotomy that allowed a full inspection and palpation were
enrolled in the study. In total, 120 operations were performed in these 91
patients. Patients who had VATS or a vertical mini-thoracotomy were ex-
cluded from the study because complete manual palpation is difficult in
these patients. Two patients had unresectable disease due to great vessel in-
vasion. These 2 patients were also excluded from the analysis because the
exact number of pulmonary metastases could not be ascertained. Seven pa-
tients with CRC had thoracotomy and pulmonary resection for suspected
metastatic lesions, which proved to be benign. These 7 patients were
excluded from the analysis. The preoperativeworkup included physical ex-
amination, chest radiograph, helical chest CT scan (5-mm cut), pulmonary
function testing, CEA level, flexible colonoscopy, abdominal CT scan to
rule out local recurrence, and radionuclide bone scan to rule out bone me-
tastases. Positron emission tomography scan was not routinely used in the
preoperativeworkup strategy because the health insurance did not cover the
expense in this group of patients in the country. The criteria for resection
included primary tumor under control (ie, no local recurrence of primary
CRC), no extrapulmonary metastases, medically stable for surgery, and
the possibility of complete resection based on the CT scan findings. The lat-
erality and number of pulmonary nodules on the CT scan during the preop-
erative study were reevaluated by 1 chest surgeon and a radiologist with
specialized training in reading chest CT images (M-H.W). Patient demo-
graphic data were retrospectively collected. The difference in the number
of pulmonary metastases as determined by interpretation of the preopera-
tive CT scan and on the final pathologic report was analyzed.
Statistical Analyses
The chi-square test was used to compare the data between the subgroups.
Multivariate analysis adjusted for confounding factors was performed using
the Cox regression model and the forward stepwise method, incorporating
all variables found to be significant in univariate analysis. Factors related to
additional malignant lesion were analyzed with logistic binary regression.
All calculations were performed using the Statistical Package for the Social
Sciences, version 12.0 (SPSS, Inc, Chicago, Ill).
RESULTS
Patient Demographic and Operative Data
The demographic data of the 91 patients are shown in
Table 1. There were 59 male patients (65%) and 32 female1208 The Journal of Thoracic and Cardiovascular Surpatients (35%) with a mean age of 65.0 years (range, 36–89
years). The primary carcinoma was located in the colon in
54 patients (59%) and in the rectum in 37 patients
(41%). The mean disease-free interval (interval between
resection of the primary tumor and the diagnosis of lung
metastases) was 33.5 months (range, 0–192 months; me-
dian, 24 months). Sixty-eight patients (74.6%) received
a unilateral thoracotomy, including 6 patients who received
a re-thoracotomy for pulmonary metastasis. Five patients
(5.5%) underwent a synchronous bilateral thoracotomy
for bilateral lung metastases, and 18 patients (19.8%) un-
derwent a staged bilateral thoracotomy for bilateral lung
metastasis. Of these 18 patients, 5 (5.5%) received bilateral
thoracotomies when contralateral lung metastases were
subsequently discovered. There were no operative or in-
hospital mortalities and major morbidity. Operative data
are summarized in Table 2. The maximum number of pul-
monary nodules on the CT scan in our study was 20. In 2
patients having pneumonectomy for pulmonary metastases,
the lesions were large and centrally located. One patient had
1 lesion, and 1 patient had 2 lesions. There were no extra
nodules identified in these 2 cases. In patients undergoing
lobectomy, 17 of 21 had solitary lesion (80.9%). Only 1 pa-
tient had extra nodules in the same lobe (4.7%). The CEA
level was elevated in 46 of 120 operations (cutoff value,
 6.0 ng/mL). The mean size of the tumor removed was
2.68 cm (range, 0.3–9.0 cm).
Possibility of Additional Benign and Metastatic
Lesions Found during Surgery
The results of the univariate analysis of the possibility of
additional benign and metastatic lesions found during the
120 operations are shown in Tables 3 and 4. The operative
findings were consistent with the preoperative CT scan
reports in 64 operations (53.3%). In 24 operations (20%),
additional benign lesions were found at thoracotomy. A
total of 57 of 368 pulmonary lesions (15.4%) resected
were benign. Patients with unilateral and solitary lung
lesion on preoperative chest CT scan were more likely to
have additional benign lung lesions (P ¼ .043). In 32 of
the 120 operations (26.7%), additional malignant tumors
were identified at open thoracotomy. Patients with Dukes’
stage C and D, disease-free interval less than 36 months, el-
evated preoperative CEA level, and suspected bilateral or
multiple metastatic lesions demonstrated on preoperative
chest CT scan were found to have more malignant meta-
static lesions during their operations than indicated by CT
scan. The sensitivity in detection of pulmonary metastasis
varied from 35.5% to 95.5%. For patients with 1 to 3 nod-
ules (108 operations) on preoperative CT scan, disease-free
interval, tumor number, and laterality on CT are still signif-
icant predictive factors for additional malignant lesions.
The results of the multivariate analysis of the possibility
of additional malignant lesion are shown in Table 5.gery c May 2011
TABLE 1. Characteristics of the 91 patients with colorectal cancer
and pulmonary metastases
Demographics No. (%)
Age, mean (range) 65.02 y (36–89)
<65 y 40 (44%)
65 y 51 (56%)
Gender
Male 59 (65%)
Female 32 (35%)
Site of primary tumor
Colon 54 (59%)
Rectum 37 (41%)
Grade of primary tumor
Dukes’ A 9 (10%)
Dukes’ B 29 (32%)
Dukes’ C 40 (44%)
Dukes’ D 13 (14%)
Appearance of metastasis
Synchronous 10 (11%)
Metachronous 81 (89%)
Disease-free interval, mean (range) 33.47 mo (0–192)
<36 mo 56 (61.5%)
36 mo 35 (38.5%)
Approaches
Unilateral thoracotomy 68 (74.6%)
Synchronous bilateral thoracotomy 5 (5.5%)
Bilateral thoracotomy 18 (19.8%)
TABLE 2. Features of the 120 pulmonary metastasectomies in 91
patients with colorectal cancer
Demographics No. (%)
No. of lesions on CT
1 65 (54.2%)
2 34 (28.3%)
3 9 (7.5%)
4 12 (10%)
Laterality on CT
Unilateral 68 (56.7%)
Solitary 44
Multiple 24
Bilateral 52 (43.3%)
Solitary 21
Multiple 31
Pre-thoracotomy serum CEA level
Normal 74 (61.7%)
Elevated 46 (85.1%)
No. of metastatic lesion resected
1 63 (52.5%)
2 29 (24.2%)
3 8 (6.7%)
4 20 (16.7%)
Tumor size, mean (range) 2.68 cm (0.3–9.0)
3 cm 68 (56.7%)
>3 cm 52 (43.3%)
Operative procedures
Wedge resection 97 (80.8%)
Lobectomy 21 (17.5%)
Pneumonectomy 2 (1.7%)
CT, Computed tomography; CEA, carcinoembryonic antigen.
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SA unilateral solitary lesion revealed on preoperative chest
CT scan was an independent factor for the prediction of
additional malignant metastatic lesions compared with the
other factors.DISCUSSION
The prognosis of patients with CRC is determined by
local or distant recurrence after resection of the primary tu-
mor. For patients with pulmonary metastases, significant
prognostic factors are reported to include tumor resectabil-
ity, tumor stage, number of pulmonary metastases, size of
metastases, laterality of metastases, resection margin, hilar
or mediastinal lymph nodemetastases, disease-free interval,
and pre-thoracotomy serum CEA level.1-8 Helical CT scan
is the primary diagnostic tool used to detect pulmonary
metastases and quantify the tumor number and size and
identify location. The literature concerning the accuracy
and sensitivity of a preoperative CT scan in the detection
of pulmonary metastases in patients with CRC is limited.
The results of this study indicated that the sensitivity of
CT in the detection of pulmonary metastatic lesions in
patients with CRC varied from 35.5% to 95.5%. Patients
with an early-stage primary tumor (especially Dukes’ A),
disease-free interval more than 36 months, normal pre-
thoracotomy CEA level, and unilateral solitary metastasis
were likely to have fewer additional metastatic lesions.
These factors are also favorable prognostic factors accord-The Journal of Thoracic and Caring to reports in the literature.1,2,4 We assume that fewer
additional metastatic lesions found during surgery in these
patients may indicate relatively benign tumor behavior
and a low occult metastasis rate. Some previous studies
also recommended that VATS can be used in patients with
early-stage and fewer metastases.15,16
The traditional principle for resection of pulmonary me-
tastases is to completely remove all the metastatic lesions
detected by CT scan if possible. Open thoracotomy is thus
recommended as the procedure of choice, because only
manual palpation during surgery can ensure removal of all
metastatic lesions, which is the limitation of VATS.17,18
However, some authors have suggested that the use of
VATS does not result in inferior overall survival
compared with thoracotomy in patients with CRC with
pulmonary metastases.15,16,19 This study carefully
examined the patients undergoing open thoracotomy for
pulmonary metastases from CRC and focused on the
accuracy of detection of metastatic lesions by use of the
CT scan in conjunction with thorough palpation during
surgery. The overall detection rate of additional metastatic
lesions was 26.7% at open thoracotomy. We observed
that additional metastatic lesions were found in 2 of 44
thoracotomies (4.5%) in patients with unilateral solitarydiovascular Surgery c Volume 141, Number 5 1209
TABLE 3. Univariate analysis of the possibility of additional benign
lesions
Demographics No. (%)
Additional
benign (%)
P
value
Age .314
<65 y 56 (46.7%) 9 (16.1%)
65 y 64 (53.3%) 15 (23.4%)
Gender .925
Male 76 (63.3%) 15 (19.7%)
Female 44 (36.7%) 9 (20.5%)
Site of primary tumor 1.00
Colon 70 (58.3%) 14 (20.0%)
Rectum 50 (41.7%) 10 (20.0%)
Grade of primary tumor .307
Dukes’ A and B 49 (40.8%) 12 (24.5%)
Dukes’ C and D 71 (59.2%) 12 (16.9%)
Disease-free interval .849
<36 mo 77 (64.2%) 15 (19.5%)
36 mo 43 (35.8%) 9 (20.9%)
Pre-thoracotomy CEA level .925
Within normal 74 (61.7%) 15 (20.3%)
Elevated 46 (38.3%) 9 (19.6%)
Tumor number on CT .051
1 65 (54.2%) 18 (27.7%)
2 34 (28.3%) 6 (17.6%)
3 9 (7.5%) 0 (0%)
4 12 (10.0%) 0 (0%)
Tumor laterality on CT .043*
Unilateral 68 (56.7%) 18 (26.5%)
Bilateral 52 (43.3%) 6 (11.5%)
Tumor laterality and number
on CT
.043*
Unilateral solitary 44 (36.7%) 13 (29.5%)
Unilateral multiple 24 (20.0%) 5 (20.8%)
Bilateral solitary 21 (17.5%) 5 (23.8%)
Bilateral multiple 31 (25.8%) 1 (3.2%)
Tumor size .598
3 cm 90 (75.0%) 19 (21.1%)
>3 cm 30 (25.0%) 5 (16.7%)
Operative methods
Wedge resection 97 (80.8%) 22 (22.7%) .132
Anatomic resection 23 (19.2%) 2 (8.7%)
CT, Computed tomography; CEA, carcinoembryonic antigen. *P<.05 was consid-
ered significant by chi-square test.
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Slesions demonstrated by a preoperative CT scan, which was
significantly lower than in patients with multiple or bilateral
lesions as revealed by CT scan. Age, gender, and site of the
primary tumor were not correlated with the detection rate of
additional metastatic lesions. Kayton and colleagues20 re-
ported that only an approximate correlation exists between
CT findings and the number of lesions identified at thoracot-
omy in cases of pulmonary metastases from osteosarcoma.
The authors suggested that minimal access procedures
should not be the approach of choice in these patients. An-
other study also reported that helical CT scans miss metas-
tases in more than 40% of cases of pulmonary metastases1210 The Journal of Thoracic and Cardiovascular Surfrom various origins.12 In a prospective study that enrolled
166 patients with lung cancer undergoing lung resection via
thoracotomy, additional malignant lesions that were not de-
tected by preoperative CT scans, and which could possibly
be missed by VATS, were identified in 14 patients (8.4%).21
In contrast, another study of 102 patients with CRC with
pulmonary metastases found that the ability to detect pul-
monary metastases was limited by preoperative CT scan
and surgical techniques. The authors concluded that finger
palpation for detecting additional pulmonary nodules at
metastasectomymight play only a limited role in improving
the postoperative outcome of patients with pulmonary me-
tastasis from CRC, especially when the pulmonary lesions
are small.22
There are 3 issues to consider for patients with pulmo-
nary metastases revealed by CT scan. The first is whether
the sensitivity of a CT scan is sufficient. The second is
whether the surgeon can identify all the metastatic lesions
via open thoracotomy in every operation by use of a finger
palpation. The third is whether complete removal of all met-
astatic lesions is possiblewhenmany lesions are present and
whether a patient’s prognosis is improved by their removal.
With the evolution of CT scanning technology, helical CT
scanning can detect smaller pulmonary nodules than older
technology.23 In this study, standard-dose helical CT scan
was used in all patients for screening of pulmonary metas-
tases. According to the results from Margaritora and
colleagues,11 the sensitivity of helical CT is better than
high-resolution CT (82.1% vs 75%), possibly because
there is a 10-mm gap in high resolution CT. High-
resolution CT is to assess a generalized lung disease with
1-mm thick images taken at 10-mm spacings. It is unsuit-
able for assessment of lung cancer or other localized lung
disease. There are also some differences between
standard-dose CT and low-dose CT. The radiation dose of
low-dose CT can be reduced to approximately 10% to
20% of standard-dose CT (0.3–0.55 mSv vs 3–27 mSv),
which is acceptable for repeat examination. In addition,
low-dose CT can be completed in a single breath-hold with-
out contrast medium injection, which can avoid the risk of
anaphylaxis and acute renal failure. However, the number
of pulmonary nodules detected by low-dose CTwas signif-
icantly less than those detected by standard-dose CT,
especially for nodules smaller than 5 mm. Even with im-
provements in CT scanning, the question remains whether
the use of VATS is justified in treating pulmonary metasta-
ses from CRC. A 2008 study concluded that there was sig-
nificant difference in the survival of patients with CRC with
pulmonary metastases who underwent thoracotomy or thor-
acoscopy.24 In contrast, a 2009 study that reported an
11-year experience of resection of pulmonary metastases
suggested that VATS is inferior to conventional open thora-
cotomy and was not recommended as a standard proce-
dure.25 Some authors have advocated that VATS can begery c May 2011
TABLE 4. Univariate analysis of the possibility of additional malignant lesions and sensitivity of preoperative computed tomography scan
Demographics No. (%) Additional malignant (%) Sensitivity of CT scan (%) P value
Age .204
<65 y 56 (46.7%) 18 (32.1%) 67.9%
65 y 64 (53.3%) 14 (21.9%) 78.1%
Gender .162
Male 76 (63.3%) 17 (22.4%) 77.6%
Female 44 (36.7%) 15 (34.1%) 65.9%
Site of primary tumor .485
Colon 70 (58.3%) 17(24.3%) 75.7%
Rectum 50 (41.7%) 15 (30.0%) 70%
Grade of primary tumor .011*
Dukes’ A and B 49 (40.8%) 7 (14.3%) 85.7%
Dukes’ C and D 71 (59.2%) 25 (35.2%) 64.8%
Disease-free interval .001*
<36 mo 77 (64.2%) 28 (36.4%) 63.6%
36 mo 43 (35.8%) 4 (9.3%) 90.7%
Pre-thoracotomy CEA level .015*
Within normal 74 (61.7%) 14 (18.9%) 81.1%
Elevated 46 (38.3%) 18 (39.1%) 60.9%
Tumor number on CT <.001*
1 65 (54.2%) 6 (9.2%) 90.8%
2 34 (28.3%) 10 (29.4%) 70.6%
3 9 (7.5%) 4 (44.4%) 55.6%
4 12 (10.0%) 12 (100%) 0%
Tumor laterality on CT <.001*
Unilateral 68 (56.7%) 8 (11.7%) 88.3%
Bilateral 52 (43.3%) 24 (46.2%) 53.8%
Tumor laterality and number on CT <.001*
Unilateral solitary 44 (36.7%) 2 (4.5%) 95.5%
Unilateral multiple 24 (20.0%) 6 (25.0%) 75.0%
Bilateral solitary 21 (17.5%) 4 (19.0%) 81.0%
Bilateral multiple 31 (25.8%) 20 (64.5%) 35.5%
Tumor size 1.00
3 cm 90 (75.0%) 24 (26.7%) 73.3%
>3 cm 30 (25.0%) 8 (26.7%) 73.3%
Operative methods
Wedge resection 97 (80.8%) 28 (28.9%) 71.1% .263
Anatomic resection 23 (19.2%) 4 (17.4%) 82.6%
CT, Computed tomography; CEA, carcinoembryonic antigen. *P<.05 was considered significant by chi-square test.
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Sused as an acceptable alternative in selected patients with
small pulmonary metastases, fewer nodules, and peripheral
lesions.15,16 However, for patients with deeply located
metastatic lesions, it would be difficult to identify or
resect the lesions by VATS. In this study, CT scan
sensitivity is approximately 95% in patients with only 1
metastatic lesion in lungs. For patients with multiple
metastases in 1 or both lungs, however, the sensitivity of
CT scanning is poor. We consider that multiple
pulmonary metastases indicated advanced disease. More
occult metastatic lesions were possibly missed on CT
scan. This study found that the sensitivity of CT scan in
patients with more than 3 pulmonary lesions or bilateral
multiple lesions was even poorer. The sensitivity of the
CT scanning was not influenced by the tumor size. TheThe Journal of Thoracic and Carpresent results indicate that VATS may be feasible and
justified in patients with CRC with solitary pulmonary
metastases. However, even with high sensitivity of CT
scan, for patients with unilateral solitary lesion, there was
still a 5% or greater chance that additional malignant
lesions could be missed if the patients underwent VATS.
Study Limitations
This study has several limitations to consider. First, all
the data were retrospectively collected. Although the CT
scan images were reviewed by 1 chest surgeon and 1 spe-
cialized radiologist, the operative findings were recorded
according to the operative and pathologic reports. Some
bias might exist, such as the involvement of different sur-
geons over the time of the study. For example, results ofdiovascular Surgery c Volume 141, Number 5 1211
TABLE 5. Multivariate analysis of the possibility of additional
malignant lesions
Variable OR 95% CI P value
Grade of primary tumor
Dukes’ A and B 1
Dukes’ C and D 2.311 0.748–7.133 .145
Disease-free interval
36 mo 1
<36 mo 3.356 0.084–1.063 .062
Pre-thoracotomy CEA level
Normal 1
Elevated (>6 ng/mL) 2.372 0.854–6.586 .097
Tumor laterality and number
on CT
Unilateral solitary 1
Unilateral multiple 9.010 1.325–44.867 .023*
Bilateral solitary 7.349 0.907–37.009 .063
Bilateral multiple 33.665 5.415–144.207 <.001*
OR,Odds ratio;CI, confidence interval;CT, computed tomography;CEA, carcinoem-
bryonic antigen. Multivariate analysis was performed using the Cox regression
model. *P<.05 was considered significant.
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Sfinger palpation or the findings of additional metastatic le-
sions may not be consistent in all cases. Second, we looked
only at the relationship between preoperative CT images
and operative findings, and investigated whether demo-
graphic data would influence the detection rates of addi-
tional pulmonary metastatic lesions. We did not follow up
the patients in the postoperative period to see whether early
recurrence was more likely to develop in patients with mul-
tiple pulmonary metastases. Long-term follow-up or a pro-
spective trial may be required to evaluate the effectiveness
of helical CT scan in the detection of pulmonary metastases
in patients with CRC and appropriate indications for VATS
in these patients.CONCLUSIONS
The sensitivity of helical CT scanning in detection of pul-
monary metastases can reach 95% in patients with CRC
with unilateral solitary metastatic lesion. With thorough
palpation during surgery, patients with early-stage disease
(especially Dukes’ A), disease-free interval more than 36
months, normal pre-thoracotomy CEA level, and unilateral
solitary metastases were likely to have fewer additional
metastatic lesions. Unilateral solitary lesion demonstrated
on a preoperative CT scan is an independent factor for pre-
diction of additional metastatic lesions. We suggest that
VATS is justified in patients with CRC with unilateral
solitary pulmonary metastasis, if feasible.References
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